Mark Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.8M | Buy |
|
|||||
|
2021
Q3 | $1.04M | Sell |
|
|||||
|
2021
Q2 | $3.05M | Sell |
|
|||||
|
2021
Q1 | $6.39M | Sell |
|
|||||
|
2020
Q4 | $14.4M | Sell |
|
|||||
|
2020
Q3 | $6.43M | Sell |
|
|||||
|
2020
Q2 | $4.36M | Buy |
|
|||||
|
2020
Q1 | $2.85M | Buy |
|
|||||
|
2019
Q4 | $1.16M | Sell |
|
|||||
|
2019
Q3 | $1.05M | Sell |
|
|||||
|
2019
Q2 | $1.46M | Hold |
|
|||||
|
2019
Q1 | $1.64M | Buy |
|
|||||
|
2018
Q4 | $411K | Buy |
|